About Brandywine Medical Associates
Services
Type of Care
Substance use treatment; Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient detoxification; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone
Pharmacotherapies
Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (extended-release, injectable); Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Relapse prevention
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
SAMHSA certification for opioid treatment program (OTP)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use
Testing
Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Discharge Planning; Naloxone and overdose education
Detoxification (medical withdrawal) Services
Alcohol Detoxification; Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Integrated primary care services
Type of Care
Substance use treatment; Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient detoxification; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone
Pharmacotherapies
Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (extended-release, injectable); Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Relapse prevention
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
SAMHSA certification for opioid treatment program (OTP)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use
Testing
Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Discharge Planning; Naloxone and overdose education
Detoxification (medical withdrawal) Services
Alcohol Detoxification; Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Integrated primary care services
